StonvexLoading…
StonvexStonvexStonvexCore line items from CVX's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $184.43B | $193.41B | $196.91B | $235.72B |
Operating Income | $19.74B | $27.51B | $29.58B | $49.67B |
Net Income | $12.30B | $17.66B | $21.37B | $35.47B |
EPS (Diluted) | $6.63 | $9.72 | $11.36 | $18.28 |
Total Assets | $324.01B | $256.94B | $261.63B | $257.71B |
Total Liabilities | $131.84B | $103.78B | $99.70B | $97.47B |
Cash & Equivalents | $7.29B | $8.26B | $8.18B | $17.68B |
Free Cash Flow OCF − CapEx | $16.59B | $15.04B | $19.78B | $37.63B |
Shares Outstanding | 1.86B | 1.82B | 1.88B | 1.94B |